\(^O^)/ try FastEmoji.com easy search emojis to copy-paste

Ovarian Cancer: A New Indication for Bevacizumab

Say and pronounce Ovarian Cancer: A on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Thomas Herzog, MD, discusses recent progress in treating advanced ovarian cancer and reviews the most recent FDA indication for bevacizumab use in patients with recurrent platinum-sensitive disease.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  Bevacizumab for Recurrent Ovarian Cancer   Patient Selection for Bevacizumab in Ovarian Cancer   Hundreds come out to support Ovarian Cancer Run   When to Add Bevacizumab for Recurrent Ovarian Cancer   Dose-Dense Chemotherapy for Ovarian Cancer; Adding Bevacizumab   Scientists make the most progress: in ovarian cancer for 10 years.   NEW TREATMENT IN THE FIGHT AGAINST OVARIAN CANCER   New developments in fight against ovarian cancer   Why Ovarian Cancer is no longer called the "silent killer"   Ovarian & Cervical Cancer Prognosis | American Oncology Institute | TV5 News   Dr. Mirza on Niraparib Plus Bevacizumab Combo in Ovarian Cancer   New ovarian cancer research offers options   The Signs, Symptoms, and Treatment of Ovarian Cancer   FDA Approvals in Ovarian Cancer and Merkel Cell Carcinoma   Scientists have made the biggest breakthrough in the treatment of ovarian cancer   New screening for ovarian cancer   Best treatment for ovarian cancer   90% of women do not know all of the symptoms of ovarian cancer   Cooking For A Good Cause   Looking Forward To This Weekend’s MOCA Gala   Dr. Swisher on Next Steps of Treatment for Ovarian Cancer   Ovarian cancer 'simple rules' for ultrasound scans may improve diagnosis   Colorado teen's cancer survival story featured in commercial to air during the Oscars   These Guys Are Raising Awareness About Ovarian Cancer   The facts about ovarian cancer   One Woman's Journey with Ovarian Cancer   The Changing Landscape in Advanced Ovarian Cancer   Assessing the Use of Bevacizumab   Metastatic and Recurrent Cervical Cancer Treatment   Bedford woman hosts fashion show to raise ovarian cancer awareness   Ask the Expert: Ovarian Cancer Awareness Month   FDA Approvals in ALL, Ovarian Cancer, Priority Review in CTCL, and sNDA Submitted in RCC   Annual Zoo Walk to fight Ovarian Cancer   Rucaparib for Ovarian Cancer   Local Ovarian Cancer Survivor Shares Story   NDA Withdrawn in Melanoma, Promising Phase III Results in Breast Cancer and Ovarian Cancer, and More   New Insights About Ovarian Cancer   Denver's Jodi's Race now one of the largest in the country   Cancer survivor talks about the difficulties post-chemo   Johnson & Johnson to pay woman $110M for causing her cancer   Wheels and Teal event to fight ovarian cancer   Dr. Powles on Bevacizumab Plus Atezolizumab in Kidney Cancer   Ovarian Cancer hard to diagnose   Johnson & Johnson Ordered To Pay $417 Million In Baby Powder Lawsuit   Higher survival rate of ovarian cancer with IV/IP treatment   Taking all she's learned about her ovarian cancer and helping others   Dr. Moore on the NOVA Trial for Ovarian Cancer   Emerging Immunotherapy Combinations in Kidney Cancer   A Tasty Teal Cocktail for a Great Cause   Dr. Brown on Genetic Counseling for Breast and Ovarian Cancer   Dr. Barber on Neoadjuvant Chemotherapy in Ovarian Cancer   Our Stories: Robin's Good Day   Dr. Barber on Chemotherapy Versus Surgery for Ovarian Cancer   Robotic Surgery - Gynecologic Cancer - Dr Mazdak Momeni   Maintenance Strategies in Lung Cancer   FDA Approval and Priority Review in Ovarian Cancer, End of Part B Payment Model, and More   Key Considerations for Treating Recurrent Ovarian Cancer   Women With Gene Mutations At Higher Risk For Breast Cancer   Ovarian Cancer: Current and Novel Treatment Strategies   Ovarian Cancer -- A Survivor’s Story   Johnson & Johnson faces $417 million payout   Robotic Surgery - Gynecologic Cancer - Dr Mark Genesen   Positivley Tampa Bay: Old Salt   Diem Brown talks second ovarian cancer diagnosis   Cancer Development | 9 News Perth   Ovarian Cancer Awareness: Mayo Clinic Radio   Johnson & Johnson ordered to pay $417 million in talcum powder case   Chemotherapy Regimens for Ovarian Cancer   Young Bodybuilder Documents Cancer Fight on Instagram   Sequencing Therapies for Ovarian Cancer   Rucaparib for Recurrent Ovarian Cancer   Cytoreductive Surgery for Ovarian Cancer   Fake Cancer: woman charged   Dr. Levine on Precision Medicine for Ovarian Cancer   Pierce Brosnan's Daughter Dies

Popular Today